why choose us

First received: May 02, 2023

Clinical Trial: Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Metastatic Solid Tumors

Study Type: INTERVENTIONAL


Official Title: A Phase 1/1b Open-label, Multicenter Clinical Study of MK-0472 as Monotherapy and Combination Therapy in Participants With Advanced/Metastatic Solid Tumors.

Brief Summary: The purpose of this study is to assess the efficacy, safety, and tolerability of MK-0472 administered as monotherapy and in combination with pembrolizumab (MK-3475) in participants with histologically or cytologically confirmed diagnosis of advanced/metastatic solid tumors.There is no primary hypothesis to be tested for this study.

Read more